New MS Research and Treatment Advances: Highlights from ECTRIMS 2025 | Day Two

What were some of the most important new developments in multiple sclerosis research and treatment unveiled on the second day of ECTRIMS 2025? Dr. Barry Singer, Director and Founder of The MS Center for Innovations in Care, joins host Brett Drummond to unpack the key research, clinical findings, and emerging treatment developments presented during the second day of the 41st ECTRIMS Congress in Barcelona.

Together, they explore the findings generating discussion among MS experts, what they could mean for people living with multiple sclerosis, and the research and treatment advances that could help shape the future of MS care.

This podcast episode is supported by an educational grant from Alexion, AstraZeneca Rare Diseases, Bristol Myers Squibb, Novartis, Roche, Sanofi, and UCB. Educational grant providers have no input into the podcast series content.